HWPC(688799) 证券时报网·2024-10-29 02:17Core Points - Warner Pharmaceuticals has commenced the construction of a high-end raw materials and advanced pharmaceutical intermediates project in Wangcheng Economic Development Zone, marking its second investment in the area after the chiral drug project [1] - The new project will cover over 230 acres and is expected to produce 3,000 tons of high-end raw materials and intermediates annually, contributing to the establishment of a 10 billion-level biopharmaceutical industry cluster in Wangcheng [1] Summary by Sections Project Overview - The new project is part of Warner Pharmaceuticals' strategy to enhance its production capabilities and is expected to significantly boost the local biopharmaceutical industry [1] - The company has previously established a chiral drug manufacturing facility in the same region, which has become a leading enterprise in the local biopharmaceutical sector [1] Technological Upgrades - The project will implement three major upgrades: 1. Utilizing synthetic biology research to promote a green transformation in chemical synthesis processes [2] 2. Introducing continuous reaction systems for chemical processes to enhance safety and automation in production [2] 3. Aligning with international standards to improve product quality and increase market share in international markets [2] Regional Development - The Copper Official Industrial Zone is the only provincial-level chemical park in Changsha, providing a unique advantage for the development of the biopharmaceutical industry [2] - The local government is committed to creating an optimal environment for project construction and supporting enterprises in the biopharmaceutical sector to explore new fields and achieve new heights [2]